As one step in defining the clinical relevance of exposure to an allergen i
dentified with patch testing, use tests (provocative use test (PUT), and re
peated open application test (ROAT)) have been used. In 1/2 of the cases of
seemingly reliable patch tests, use tests are negative, suggesting that th
e patient's biologic threshold of response had not been reached with open a
pplication dosing. Dramatic differences exist in regional skin reactivity a
nd percutaneous penetration. Negative results of use tests on normal skin m
ay become positive on diseased skin. To refine this assay further, more con
trolled observations and analysis of reaction differences between normal an
d damaged skin, and among regional anatomic sites might be performed. In ad
dition, we require a standardized measurement for the results. Use testing
has significant potential in refinement of the evidence-based diagnosis of
clinical relevance. However, for general validation, we should fill the def
iciencies described above.